Cytodyn Inc (CYDY)

[misiu143]

Give me p-value of all the drugs from SOC and others leronlimab was against , and then only we may talk about p-value here .

They didn’t give us those value , they compare mortality benefit of all those drugs , as this what is the most important for all of our patients , and this is ONLY what we may talk here .
What was given to us ..mortality benefit. ..

And in our CD12 at 14 days , when drug was in the system in critical ,
We saw 82% mortality benefit in leronlimab group ABOVE any other drug .

That many more survived with LL .

And to EVERY patients and every doctor , this is the only important thing .,

So you statisticians , if you are , concentrate on p-value , I will concentrate on survival ..

Even Dr Woodcock in some speeches said ..

People don’t want us to approve this or this drug because p-value was not the best , but we saw other important things happening with this drug

“ do you want patients to die for a p-value “

No

Saying that , we don’t know what was a P-value at 14 days , I suspect it would be very good ..

And it is very difficult to show 82% of anything in 62 patients .only the best drugs can do it .,

This is why B.P. drugs which we know now is often a junk with severe side effects , doing a studies with thousands of patients , and they looking for some small things here and there to approve these drugs .

To show 82% mortality benefit ABOVE any other drug , in 62 patients , happens only with the best .

But we also have over 100 compassionate , and RTT with the same results .

FDA is not stupid , they saw LL saving lives , but they still stayed with remdesivir for us .,

How you like that .,

All imo